All public logs
Jump to navigation
Jump to search
Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 13:31, 22 February 2024 Mohammad Nikoohemmat talk contribs created page Birch triterpenes (Created page with "{{DrugProjectFormSinglePage |authorTag=Mohammad Nikoohemmat |genericName=birch triterpenes }}")
- 13:24, 22 February 2024 Mohammad Nikoohemmat talk contribs created page Eplontersen (Created page with "{{DrugProjectFormSinglePage |authorTag=Mohammad Nikoohemmat |genericName=Eplontersen |aOrAn=a |drugClass=transthyretin-directed antisense oligonucleotide |indicationType=treatment |indication=WAINUA is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. |adverseReactions=Most common adverse reactions (that occurred in at least 9% of patients treated with WAINUA) were vitamin A decreased and vomiting. |fdaLIADAdult...")
- 12:33, 22 February 2024 Mohammad Nikoohemmat talk contribs created page Template:MNH (Created page with "Mohammad Nikoohemmat, M.D.[mailto:mohammadnikoo1375@gmail.com]")
- 16:38, 21 February 2024 Badgettrg talk contribs created page Template:Math2 (Created page with "<span class="texhtml {{#if:{{{big|}}}{{{size|}}}|texhtml-big}}" {{#if:{{{big|}}}{{{size|}}}|style="font-size:{{{size|165%}}};"}}>{{{1}}}</span><!-- -->{{#invoke:Check for unknown parameters|check | unknown = {{main other|_VALUE_}} | showblankpositional=1 | preview = unknown parameter "_VALUE_" (consider using <code>{{!}}1=</code>, <code><nowiki>{{!}}</nowiki></code>, <code><nowiki>{{=}}</nowiki></code>) | 1 | big | si...")
- 06:21, 21 February 2024 Alen Antony talk contribs created page Olutasidenib (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=Olutasidenib |aOrAn=a |drugClass=isocitrate dehydrogenase-1 (IDH1) inhibitor |indicationType=treatment |indication=relapsed or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. |hasBlackBoxWarning=Yes |adverseReactions=nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, mucositis, arthralgia, fatigue, pyrexia...")
- 14:13, 20 February 2024 Badgettrg talk contribs created page Treatment outcome (Created page with "{{SI}} {{RGB}} In Quality of Health Care, '''{{PAGENAME}}''' is defined as "Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series."<ref>{{MeSH}}</ref> ==Statistical methods== * The minimal clinically important differences (MCID) has been proposed as >0.5 standard deviation imp...")
- 15:11, 19 February 2024 Matt Pijoan talk contribs created page Template:Image (Created page with "<templatestyles src="Image/styles.css"/><div class="t-image {{#ifeq:{{{padding|}}}|no||t-image-padding}}" {{#if:{{{width|}}}|style="max-width:{{{width}}}%"}}> [[File:{{{file|File:MattP(1).png}}}|{{{imagewidth|400}}}px|{{#ifeq:{{{border|}}}|yes|border{{!}}}}alt={{{caption|}}}|{{#if:{{{link|}}}|link={{{link|}}}}}]]{{#if: {{{caption|}}}| <p class="t-image-caption"> {{{caption}}} </p>}} </div><noinclude> {{documentation|content= {{Uses TemplateStyles|Template:Image/styles.cs...")
- 16:17, 18 February 2024 Badgettrg talk contribs created page Back pain monitoring response to therapy (Created page with "__NOTOC__ {{Back pain}} {{CMG}} {{AE}} {{ZMalik}} ==Overview== The Oswestry low back pain disability questionnaire (ODQ) can measure the response to therapy.<ref name="pmid6450426">{{cite journal| author=Fairbank JC, Couper J, Davies JB, O'Brien JP| title=The Oswestry low back pain disability questionnaire. | journal=Physiotherapy | year= 1980 | volume= 66 | issue= 8 | pages= 271-3 | pmid=6450426 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi...")
- 03:15, 16 February 2024 Kosar Doraghi talk contribs created page Lasmiditan (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Lasmiditan (REYVOW) |aOrAn=a |drugClass=serotonin (5-HT) 1F receptor agonist |indicationType=treatment |indication=migraine with or without aura in adults |hasBlackBoxWarning=Yes |adverseReactions=dizziness, fatigue, paresthesia, and sedation |blackBoxWarningTitle=Warning |blackBoxWarningBody=Driving Impairment: *Central Nervous System (CNS) Depression: Do not use in combination...")
- 03:03, 16 February 2024 Kosar Doraghi talk contribs created page File:IMG 0837.jpeg
- 03:03, 16 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0837.jpeg
- 02:58, 16 February 2024 Kosar Doraghi talk contribs created page File:IMG 0839.jpeg
- 02:58, 16 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0839.jpeg
- 02:56, 16 February 2024 Kosar Doraghi talk contribs created page File:IMG 0838.jpeg
- 02:56, 16 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0838.jpeg
- 06:30, 15 February 2024 Alen Antony talk contribs created page Lenacapavir (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=lenacapavir }}")
- 02:00, 15 February 2024 Alara E. Dagsali talk contribs created page 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) (Created page with "{{ADA guidelines}} {{CMG}} {{AE}} {{SCh}}; {{MehdiP}}; {{TarekNafee}} ==2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)<ref name="pmid37622663">{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines f...")
- 01:01, 15 February 2024 Kosar Doraghi talk contribs created page Ponesimod (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Ponesimod (PONVORY) |aOrAn=a |drugClass=sphingosine 1-phosphate receptor modulator |indicationType=treatment |indication=relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults |hasBlackBoxWarning=Yes |adverseReactions=upper respiratory tract infection, hepatic transaminase elevation, and ...")
- 00:56, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0834.jpeg
- 00:56, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0834.jpeg
- 00:55, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0833.jpeg
- 00:55, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0833.jpeg
- 00:49, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0832.jpeg
- 00:49, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0832.jpeg
- 00:48, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0829.jpeg
- 00:48, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0829.jpeg
- 00:46, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0831.jpeg
- 00:46, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0831.jpeg
- 21:25, 14 February 2024 Alen Antony talk contribs created page Tirzepatide (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=tirzepatide |aOrAn=a |drugClass=glucagon-like peptide-1 (GLP-1) receptor agonist |indicationType=treatment |indication=type 2 diabetes mellitus in adults in adjunct to diet and exercise. |hasBlackBoxWarning=Yes |adverseReactions=pancreatitis,hypoglycemia with concomitant use of insulin or insulin secretagogues, acute kidney injury, severe gastrointestinal disease, acute gallbladder disease, dia...")
- 18:30, 14 February 2024 Kosar Doraghi talk contribs created page Dasiglucagon (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Dasiglucagon (ZEGALOGUE) |aOrAn=an |drugClass=anti-hypoglycemic |indicationType=treatment |indication=severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and older |hasBlackBoxWarning=Yes |adverseReactions=nausea, vomiting, headache, diarrhea, and injection site pain |blackBoxWarningTitle=Allergic reactions |blackBoxWarningBody=increase in blood pressure in Patients wi...")
- 18:17, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0828.jpeg
- 18:17, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0828.jpeg
- 18:16, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0827.jpeg
- 18:16, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0827.jpeg
- 18:13, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0822.jpeg
- 18:13, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0822.jpeg
- 18:12, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0826.jpeg
- 18:12, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0826.jpeg
- 18:07, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0824.jpeg
- 18:07, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0824.jpeg
- 18:05, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0823.jpeg
- 18:05, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0823.jpeg
- 17:59, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0820.jpeg
- 17:59, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0820.jpeg
- 17:58, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0819.jpeg
- 17:58, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0819.jpeg
- 07:05, 14 February 2024 Alen Antony talk contribs created page Spesolimab-sbzo (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=Spesolimab-sbzo |drugClass=humanized monoclonal Immunoglobulin G1 antibody |indicationType=treatment |indication=generalized pustular psoriasis (GPP) flares in adults. |adverseReactions=infections, nausea, vomiting, headache, fatigue, Infusion site hematoma and bruising. |fdaLIADAdult=SPEVIGO is indicated for the treatment of generalized pustular psoriasis (GPP) flares in adults. SPEVIGO is administer...")
- 21:57, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0813.jpeg
- 21:57, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0813.jpeg
- 21:56, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0812.jpeg
- 21:56, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0812.jpeg
- 21:54, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0817.jpeg
- 21:54, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0817.jpeg
- 21:51, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0818.jpeg
- 21:51, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0818.jpeg
- 21:50, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0816.jpeg
- 21:50, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0816.jpeg
- 21:47, 13 February 2024 Kosar Doraghi talk contribs created page Vericiguat (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=VERQUVO-vericiguat |aOrAn=a |drugClass=soluble guanylate cyclase (sGC) stimulator |indicationType=treatment |indication=heart failure with reduced ejection fraction (HFrEF), reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less t...")
- 21:43, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0815.jpeg
- 21:43, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0815.jpeg
- 03:20, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0810.jpeg
- 03:20, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0810.jpeg
- 03:18, 13 February 2024 Kosar Doraghi talk contribs created page Tapinarof (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=VTAMA- tapinarof cream |aOrAn=an |drugClass=aryl hydrocarbon receptor agonist |indicationType=treatment |indication=plaque psoriasis in adults |adverseReactions=folliculitis, nasopharyngitis, contact dermatitis, headache, and pruritus |fdaLIADAdult=Cream, 1% Each gram of VTAMA cream contains 10 mg of tapinarof in a white to off-white cream. *Apply a thin layer of VTAMA cream to affected ar...")
- 03:14, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0809.jpeg
- 03:14, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0809.jpeg
- 03:12, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0808.jpeg
- 03:12, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0808.jpeg
- 03:10, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0807.jpeg
- 03:10, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0807.jpeg
- 22:30, 12 February 2024 Alen Antony talk contribs created page Mosunetuzumab-axgb (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=mosunetuzumab-axgb |aOrAn=a |drugClass=humanized monoclonal antibody |indicationType=treatment |indication=relapsing or refractory follicular lymphoma in adults after 2 or more lines of systemic therapy. |hasBlackBoxWarning=Yes |adverseReactions=cytokine release syndrome, fatigue, rash, pyrexia, and headache. |blackBoxWarningTitle=Cytokine Release Syndrome (CRS) |blackBoxWarningBody=Cytok...")
- 17:40, 12 February 2024 Kosar Doraghi talk contribs created page Spevigo- spesolimab-sbz (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=spesolimab-sbzo |aOrAn=an |drugClass=interleukin-36 receptor antagonis |indicationType=treatment |indication=generalized pustular psoriasis flares in adults |hasBlackBoxWarning=Yes |adverseReactions=asthenia and fatigue, nausea and vomiting, headache, pruritus and prurigo, infusion site hematoma and bruising, and urinary tract infection. |blackBoxWarningTitle=Warning: Hyp...")
- 22:23, 11 February 2024 Edzelco talk contribs created page Mavacamten (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=mavacamten |aOrAn=a |drugClass=cardiac myosin inhibitor |indicationType=treatment |indication=adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms |hasBlackBoxWarning=Yes |adverseReactions=dizziness (27%) and syncope (6%) |blackBoxWarningTitle=WARNING: RISK OF HEART...")
- 06:13, 11 February 2024 Alen Antony talk contribs created page Template:AAP (Created page with "Alen Antony Pathil, M.D.[mailto:alenantony657@gmail.com]")
- 19:04, 10 February 2024 Edzelco talk contribs created page Oteseconazole (Created page with "{{DrugProjectFormSinglePage |genericName=oteseconazole |aOrAn=an |drugClass=azole antifungal |indicationType=prevention |indication=recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential |adverseReactions=headache and nausea |fdaLIADAdult=VIVJOA Capsules: 150 mg of oteseconazole in lavender hard gelatin capsules imprinted with OTE 150 in black ink. Fluconazole is not supplied in the carton. |co...")
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA label3.png
- 19:02, 10 February 2024 Edzelco talk contribs uploaded File:VIVJOA label3.png
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA label2.png
- 19:02, 10 February 2024 Edzelco talk contribs uploaded File:VIVJOA label2.png
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA label.png
- 19:02, 10 February 2024 Edzelco talk contribs uploaded File:VIVJOA label.png
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA structure.png
- 19:02, 10 February 2024 Edzelco talk contribs uploaded File:VIVJOA structure.png
- 06:17, 10 February 2024 Kosar Doraghi talk contribs created page Ublituximab-xiiy (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=BRIUMVI™ (ublituximab-xiiy |aOrAn=a |drugClass=CD20-directed cytolytic antibody |indicationType=treatment |indication=relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults |hasBlackBoxWarning=Yes |adverseReactions=infusion reactions and upper respiratory...")
- 06:14, 10 February 2024 Kosar Doraghi talk contribs created page File:IMG 0806.jpeg
- 06:14, 10 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0806.jpeg
- 06:13, 10 February 2024 Kosar Doraghi talk contribs created page File:IMG 0805.jpeg
- 06:13, 10 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0805.jpeg
- 06:09, 10 February 2024 Kosar Doraghi talk contribs created page File:IMG 0799.jpeg
- 06:09, 10 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0799.jpeg
- 22:35, 7 February 2024 User account Alen Antony talk contribs was created by Alberto Castro Molina talk contribs
- 17:15, 7 February 2024 Kosar Doraghi talk contribs created page LYTGOBI- futibatinib (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=Futibatinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. This indication is approved under accelerated approval based on overall respons...")
- 05:03, 7 February 2024 Kosar Doraghi talk contribs created page File:IMG 0790.jpeg
- 05:03, 7 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0790.jpeg
- 05:01, 7 February 2024 Kosar Doraghi talk contribs created page File:IMG 0787.jpeg
- 05:01, 7 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0787.jpeg
- 04:56, 7 February 2024 Kosar Doraghi talk contribs created page File:IMG 0788.jpeg
- 04:56, 7 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0788.jpeg
- 00:47, 7 February 2024 Edzelco talk contribs created page Lutetium (177Lu) vipivotide tetraxetan (Created page with "{{DrugProjectFormSinglePage |genericName=lutetium (177Lu) vipivotide tetraxetan |aOrAn=a |drugClass=radioligand therapeutic agent |indicationType=treatment |indication=adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy |adverseReactions=fatigue, dry mout...")
- 00:44, 7 February 2024 Edzelco talk contribs created page File:Pluvicto label.png
- 00:44, 7 February 2024 Edzelco talk contribs uploaded File:Pluvicto label.png